Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreas. (Q46774145)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreas. |
scientific article |
Statements
Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreas (English)
Adrian M Senderowicz
John R Johnson
Rajeshwari Sridhara
Paul Zimmerman
Robert Justice
1696-706; discussion 1706-9, 1712, 1715